Altimmune (ALT) Retained Earnings (2010 - 2026)
Altimmune's (ALT) quarterly Retained Earnings came in at -$5.2 million in Q1 2026, up 99.1% year-on-year from -$2.6 million in Q1 2025, and down 6.01% on a QoQ basis from -$4.9 million in Q4 2025.
Altimmune (ALT) Retained Earnings (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Retained Earnings data on file, last reported at -$5.2 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.1% year-over-year to -$5.2 million in Q1 2026; TTM through Mar 2026 was -$5.2 million, a 99.1% increase from a year earlier, with the FY2025 full-year figure at -$4.9 million, up 0.9% from the prior year.
- Retained Earnings for Q1 2026 stood at -$5.2 million, down from -$4.9 million in the prior quarter.
- Over the last five years, Retained Earnings for ALT reached as high as $676.4 million in Q3 2024 and fell as low as -$581.0 million in Q1 2025.
- Historically, Retained Earnings has averaged $94.5 million across 5 years, with a median of -$5.0 million in 2025.
- Across the five-year window, Retained Earnings sank 6103.16% in 2022 and soared 13211.47% in 2024, its largest moves.
- Year by year, Retained Earnings stood at $568.4 million in 2022, then sank by 182.04% to -$466.3 million in 2023, then soared by 98.93% to -$5.0 million in 2024, then climbed by 0.9% to -$4.9 million in 2025, then retreated by 6.01% to -$5.2 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$5.2 million in Q1 2026, -$4.9 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | -5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.22 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | -5.02 Mn |
| Jun 30, 2025 | -5.04 Mn |
| Mar 31, 2025 | -580.97 Mn |
| Dec 31, 2024 | -4.97 Mn |
| Sep 30, 2024 | 676.43 Mn |
| Jun 30, 2024 | 673.08 Mn |
| Mar 31, 2024 | 668.82 Mn |
| Dec 31, 2023 | -466.33 Mn |
| Sep 30, 2023 | 590.21 Mn |
| Jun 30, 2023 | -414.02 Mn |
| Mar 31, 2023 | -5.10 Mn |
| Dec 31, 2022 | 568.40 Mn |
| Sep 30, 2022 | 566.55 Mn |
| Jun 30, 2022 | -332.71 Mn |
| Mar 31, 2022 | -312.60 Mn |
| Dec 31, 2021 | -293.17 Mn |
| Sep 30, 2021 | -5.04 Mn |
| Jun 30, 2021 | -235.77 Mn |